Manulife (Manufacturers Life Insurance)
KNSA icon

Manulife (Manufacturers Life Insurance)’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.33M Buy
67,715
+4,369
+7% +$227K ﹤0.01% 1253
2026
Q1 		$3.05M Buy
63,346
+22,917
+57% +$1.02M ﹤0.01% 1330
2025
Q4 		$1.66M Buy
+40,429
New +$1.62M ﹤0.01% 1609
2025
Q2 		– Sell
-13,919
Closed -$309K – 2957
2025
Q1 		$309K Sell
13,919
-48
-0.3% -$988 ﹤0.01% 2329
2024
Q4 		$276K Sell
13,967
-208
-1% -$4.75K ﹤0.01% 2485
2024
Q3 		$354K Buy
+14,175
New +$345K ﹤0.01% 2404
2024
Q2 		– Sell
-12,009
Closed -$237K – 3010
2024
Q1 		$237K Sell
12,009
-500
-4% -$9.77K ﹤0.01% 2518
2023
Q4 		$219K Sell
12,509
-432
-3% -$7.1K ﹤0.01% 2574
2023
Q3 		$225K Sell
12,941
-13
-0.1% -$219 ﹤0.01% 2526
2023
Q2 		$182K Buy
12,954
+542
+4% +$7.25K ﹤0.01% 2645
2023
Q1 		$134K Hold
12,412
– – ﹤0.01% 2674
2022
Q4 		$186K Sell
12,412
-1,152
-8% -$16.8K ﹤0.01% 2603
2022
Q3 		$174K Sell
13,564
-346
-2% -$3.94K ﹤0.01% 2644
2022
Q2 		$135K Sell
13,910
-88
-0.6% -$821 ﹤0.01% 2819
2022
Q1 		$139K Sell
13,998
-2,933
-17% -$31.1K ﹤0.01% 2891
2021
Q4 		$199 Sell
16,931
-794
-4% -$9.76K ﹤0.01% 2897
2021
Q3 		$202K Sell
17,725
-898
-5% -$11.7K ﹤0.01% 2981
2021
Q2 		$259K Buy
18,623
+1,607
+9% +$24.4K ﹤0.01% 2930
2021
Q1 		$315K Buy
17,016
+66
+0.4% +$1.35K ﹤0.01% 2584
2020
Q4 		$300K Buy
16,950
+1,329
+9% +$23.3K ﹤0.01% 2516
2020
Q3 		$239K Buy
15,621
+3,412
+28% +$64.1K ﹤0.01% 2454
2020
Q2 		$317K Buy
12,209
+2,121
+21% +$44.3K ﹤0.01% 2217
2020
Q1 		$156K Buy
+10,088
New +$158K ﹤0.01% 2433
2019
Q4 		– Sell
-10,514
Closed -$92K – 2891
2019
Q3 		$92K Buy
10,514
+133
+1% +$1.47K ﹤0.01% 2840
2019
Q2 		$141K Buy
+10,381
New +$161K ﹤0.01% 2795

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Manulife (Manufacturers Life Insurance)'s KNSA Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Kiniksa Pharmaceuticals (KNSA) stake by 6.9% in Q2 2026, buying an estimated $227K and bringing the position to 67,715 shares worth $4.33M. The position accounts for ﹤0.01% of the portfolio, ranked #1253.

Manulife (Manufacturers Life Insurance) first reported a position in KNSA in Q2 2019 and has held it in 25 quarters since. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 67,715 shares of Kiniksa Pharmaceuticals worth $4.33M as of Q2 2026.
  • Manulife (Manufacturers Life Insurance) bought 4,369 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $227K.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #1253 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Kiniksa Pharmaceuticals in Q2 2019 and has held it in 25 quarters since.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.